KLK10 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC) KLK10 was found to act as a functional tumor suppressor gene, and epigenetic inactivation of KLK10 is a common event contributing to NSCLC pathogenesis and, therefore, may be used as a potential biomarker (4).